DNA adducts of heterocyclic amine food mutagens: Implications for mutagenesis and carcinogenesis

Carcinogenesis

Volumn 20, Issue 3, 1999, Pages 353-368

  Schut, Herman A J ^a   Snyderwine, Elizabeth G ^b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE; HETEROCYCLIC AMINE;

BIOLOGICAL MONITORING; CARCINOGENESIS; CHEMOPROPHYLAXIS; DNA ADDUCT; FOOD PROCESSING; HUMAN; METABOLIC ACTIVATION; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0033034183     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/20.3.353     Document Type: Review

References (300)

1. Sugimura, T., Nagao, M., Kawachi, T. et al. (1977) Mutagens-carcinogens in foods, with special reference to highly mutagenic pyrolytic products in broiled foods. In Hiatt, H.H., Watson, J.D. and Winsten, J.A. (eds) Origins of Human Cancer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 1561-1577.
2. Commoner, B., Vithayathil, A.J., Dolara, P., Nair, S., Madyastha, P. and Cuca, G.C. (1978) Formation of mutagens in beef and beef extract during cooking. Science, 201, 913-916.
3. Felton, J.S. and Knize, M.G. (1991) Occurrence, identification and bacterial mutagenicity of heterocyclic amines in cooked food. Mutat. Res., 259, 205-217.
4. Felton, J.S. and Knize, M.G. (1990) Heterocyclic-amine mutagens/ carcinogens in foods. In Cooper, C.S. and Grover, P.L. (eds) Handbook of Experimental Pharmacology, vol. 94/I. Berlin, Springer-Verlag, pp. 471-502.
5. Sugimura, T. (1982) Mutagens, carcinogens and tumor promoters in our daily food. Cancer, 49, 1970-1984.
6. Wakabayashi, K., Ushiyama, H., Takahashi, M., Nukuya, H., Kim, S.-B., Hirose, M., Ochiai, M., Sugimura, T. and Nagao, M. (1993) Exposure to heterocyclic amines. Environ. Health Perspect., 99, 129-133.
7. Felton, J.S., Knize, M.G., Shen, N.H., Andresen, B.D., Bjeldanes, L.F. and Hatch, F.T. (1986) Identification of the mutagens in cooked beef. Environ. Health Perspect., 67, 17-24.
8. Sinha, R., Rothman, N., Brown, E.D. et al. (1995) High concentrations of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) occur in chicken but are dependent on the cooking method. Cancer Res., 55, 4516-4519.
9. Gross, G.A. and Grüter, A. (1992) Quantitation of mutagenic/carcinogenic heterocyclic aromatic amines in food products. J. Chromatog., 592, 271-278.
10. Jägerstad, M., Skog, K., Grivas, S. and Olsson, K. (1991) Formation of heterocyclic amines using model systems. Mutat. Res., 259, 219-233.
11. Ohgaki, H., Takayama, S. and Sugimura, T. (1991) Carcinogenicities of heterocyclic amines in cooked food. Mutat. Res., 259, 399-410.
12. Sugimura, T., Nagao, M. and Wakabayashi, K. (1996) Carcinogenicity of food mutagens. Environ. Health Perspect., 104 (suppl. 3), 429-433.
13. Adamson, R.H., Thorgeirsson, U.P., Snyderwine, E.G., Thorgeirsson, S.S., Reeves, J., Dalgard, D.W., Takayama, S. and Sugimura, T. (1990) Carcinogenicity of 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates: induction of tumors in three macaques. Jpn. J. Cancer Res., 81, 10-14.
14. Layton, D.W., Bogen, K.T., Knize, M.G., Hatch, F.T., Johnson, V.M. and Felton, J.S. (1995) Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. Carcinogenesis, 16, 39-52.
15. Takayama, S., Nakatsuru, Y., Masuda, M., Ohgaki, H., Sato, S. and Sugimura, T. (1984) Demonstration of carcinogenicity in F344 rats of 2-amino-3-methylimidazo[4,5-f]quinoline from broiled sardine, fried beef and beef extract. Jpn. J. Cancer Res. (Gann), 75, 467-470.
16. Tanaka, T., Barnes, W.S., Williams, G.M. and Weisburger, J.H. (1985) Multipotential carcinogenicity of the fried food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in rats. Jpn. J. Cancer Res. (Gann), 76, 570-576.
17. Ohgaki, H., Kusama, K., Matsukura, N., Morino, K., Hasegawa, H., Sato, S., Takayama, S. and Sugimura, S. (1984) Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract. Carcinogenesis, 5, 921-924.
18. 1 male mouse. Cancer Lett., 62, 205-209.
19. Kato, T., Migita, H., Ohgaki, H., Sato, S., Takayama, S. and Sugimura, T. (1989) Induction of tumors in the Zymbal gland, oral cavity, colon, skin and mammary gland of F344 rats by a mutagenic compound, 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Carcinogenesis, 10, 601-603.
20. Ohgaki, H., Hasegawa, H., Suenaga, M., Kato, T., Sato, S., Takayama, S. and Sugimura, T. (1986) Induction of hepatocellular carcinoma and highly metastatic squamous cell carcinomas in the forestomach of mice by feeding 2-amino-3,4-dimethylimidazo[4,5-f]quinoline. Carcinogenesis, 7, 1889-1893.
21. Kato, T., Ohgaki, H., Hasegawa, H., Sato, S., Takayama, S. and Sugimura, T. (1988) Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Carcinogenesis, 9, 71-73.
22. Kushida, H., Wakabayashi, K., Sato, H., Katami, M., Kurosaka, R. and Nagao, M. (1994) Dose-response study of MeIQx carcinogenicity in F344 male rats. Cancer Lett., 83, 31-35.
23. Ohgaki, H., Hasegawa, H., Suenaga, M., Sato, S., Takayama, S. and Sugimura, T. (1987) Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods. Carcinogenesis, 8, 665-668.
24. Ito, N., Hasegawa, R., Sano, M., Tamano, S., Esumi, H., Takayama, S. and Sugimura, T. (1991) A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Carcinogenesis, 12, 1503-1506.
25. Shirai, T., Sano, M., Tamano, S. et al. (1997) The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res., 57, 195-198.
26. Rao, C.V., Rivenson, A., Zang, E., Steele, V., Kelloff, G. and Reddy, B.S. (1996) Inhibition of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced lymphoma formation by oltipraz. Cancer Res., 56, 3395-3398.
27. Hasegawa, R., Sano, M., Tamano, S., Imaida, K., Shirai, T., Nagao, M., Sugimura, T. and Ito, N. (1993) Dose-dependence of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) carcinogenicity in rats. Carcinogenesis, 14, 2553-2557.
28. Ghoshal, A., Preisegger, K.-H., Takayama, S., Thorgeirsson, S.S. and Snyderwine, E.G. (1994) Induction of mammary tumors in female Sprague-Dawley rats by the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and effect of dietary fat. Carcinogenesis, 15, 2429-2433.
29. El-Bayoumy, K., Chae, Y.-H., Upadhyaya, P., Rivenson, A., Kurtzke, C., Reddy, B. and Hecht, S.S. (1995) Comparative tumorigenicity of benzo[a]pyrene, 1-nitropyrene and 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine administered by gavage to female CD rats. Carcinogenesis, 16, 431-434.
30. 1 mice by the food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Jpn. J. Cancer Res., 80, 1176-1178.
31. Hemminki, K. (1993) DNA adducts, mutations and cancer. Carcinogenesis, 14, 2007-2012.
32. Okamoto, T., Shudo, K., Hashimoto, Y., Kosuge, T., Sugimura, T. and Nishimura, S. (1981) Identification of a reactive metabolite of the mutagen, 2-amino-3-methylimidazo[4,5-f]quinoline. Chem. Pharm. Bull., 29, 590-593.
33. Yamazoe, Y., Shimada, M., Kamataki, T. and Kato, R. (1983) Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate. Cancer Res., 43, 5768-5774.
34. Hayashi, S., Møller, M.E. and Thorgeirsson, S.S. (1985) Genotoxicity of heterocyclic amines in the Salmonella/hepatocyte system. Jpn. J. Cancer Res. (Gann), 76, 835-845.
35. Kato, R. (1986) Metabolic activation of mutagenic heterocyclic aromatic amines from protein pyrolysates. Crit. Rev. Toxicol., 16, 307-348.
36. Kato, R. and Yamazoe, Y. (1987) Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates. Jpn. J. Cancer Res., 78, 297-311.
37. Snyderwine, E.G., Roller, P.P., Wirth, P.J., Adamson, R.H., Sato, S. and Thorgeirsson, S.S. (1987) Synthesis, purification and mutagenicity of 2-hydroxyamino-3-methylimidazolo[4,5-f]quinoline. Carcinogenesis, 8, 1017-1020.
38. Yamazoe, Y., Abu-Zeid, M., Manabe, S., Toyama, S. and Kato, R. (1988) Metabolic activation of a protein pyrolysate promutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline by rat liver microsomes and purified cytochrome P-450. Carcinogenesis, 9, 105-109.
39. Turesky, R.J., Bracco-Hammer, I., Markovic, J., Richli, U., Kappeler, A.-M. and Welti, D.H. (1990) The contribution of N-oxidation to the metabolism of the food-borne carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat hepatocytes. Chem. Res. Toxicol., 3, 524-535.
40. Rich, K.J., Murray, B.P., Lewis, I., Rendell, N.B., Davies, D.S., Gooderham, N.J. and Boobis, A.R. (1992) N-hydroxy-MeIQx is the major microsomal oxidation product of the dietary carcinogen MeIQx with human liver. Carcinogenesis, 13, 2221-2226.
41. Frandsen, H., Rasmussen, E.S., Nielsen, P.A., Farmer, P., Dragsted, L. and Larsen, J.C. (1990) Metabolic formation, synthesis and genotoxicity of the N-hydroxy derivative of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mutagenesis, 6, 93-98.
42. Turteltaub, K.W., Knize, M.G., Buonarati, M.H., McManus, M.E., Veronese, M.E., Mazrimas, J.A. and Felton, J.S. (1990) Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by liver microsomes and isolated rabbit cytochrome P450 isozymes. Carcinogenesis, 11, 941-946.
43. 3H-imidazo[4,5-f]quinoxaline to mutagenic metabolites. Mutagenesis, 9, 59-65.
44. Watanabe, J., Kawajiri, K., Yonekawa, H., Nagao, M. and Tagashira, Y (1982) Immunological analysis of the roles of two major types of cytochrome P-450 in mutagenesis of compounds isolated from pyrolysates. Biochem. Biophys. Res. Common., 104, 193-199.
45. Yamazoe, Y., Abu-Zeid, M., Yamauchi, K. and Kato, R. (1988) Metabolic activation of pyrolysate arylamines by human liver microsomes; possible involvement of a P-448-H type cytochrome P-450. Jpn. J. Cancer Res. (Gann), 79, 1159-1167.
46. McManus, M.E., Felton, J.S., Knize, M.G., Burgess, W.M., Roberts-Thomson, S., Pond, S.M., Stupans, I. and Veronese, M.E. (1989) Activation of the food-derived mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by rabbit and human liver microsomes and purified forms of cytochrome P-450. Carcinogenesis, 10, 357-363.
47. Holme, J.A, Wallin, H., Brunborg, G., Søderlund, E.J., Hongslo, J.K. and Alexander, J. (1989) Genotoxicity of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): formation of 2-hydroxamino-PhIP, a directly acting genotoxic metabolite. Carcinogenesis, 10, 1389-1396.
48. McManus, M.E., Burgess, W., Snyderwine, E. and Stupans, I. (1988) Specificity of rabbit cytochrome P-450 isozymes involved in the metabolic activation of the food derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline. Cancer Res., 48, 4513-4519.
49. PA (P-450IA2), the phenacetin O-de-ethylase, is primarily responsible for the hepatic 3-demethylation of caffeine and N-oxidation of carcinogenic arylamines. Proc. Natl Acad. Sci. USA, 86, 7696-7700.
50. Shimada, T., Iwasaki, M., Martin, M.V. and Guengerich, F.P. (1989) Human liver microsomal cytochrome P-450 enzymes involved in the bioactivation of pro-carcinogens detected by umu gene response in Salmonella typhimurium TA 1535/pSK1002. Cancer Res., 49, 3218-3228.
51. 3 450 of carcinogenic arylamines found in foods. J. Natl Cancer Inst., 81, 223-227.
52. 3450 and P450a. Mol. Carcinogen., 1, 253-259.
53. Aoyama, T., Gelboin, H.V. and Gonzalez, F.J. (1990) Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline by complementary DNA-expressed human liver P-450. Cancer Res., 50, 2060-2063.
54. McManus, M.E., Burgess, W.M., Veronese, M.E., Huggett, A., Quattrochi, L.C. and Tukey, R.H. (1990) Metabolism of 2-acetylaminofluorene and benzo[a]pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res., 50, 3367-3376.
55. Thompson, L.H., Wu, R.W. and Felton, J.S. (1991) Introduction of cytochrome P450I2 metabolic capability into cell lines genetically matched for DNA repair proficiency/deficiency. Proc. Natl Acad. Sci. USA, 88, 3827-3831.
56. Battula, N., Schut, H.A.J. and Thorgeirsson, S.S. (1991) Cytochrome P4501A2 constitutively expressed from transduced DNA mediates metabolic activation and DNA adduct formation of aromatic amine carcinogens in N1H3T3 cells. Mol. Carcinogen., 4, 407-414.
57. Probst, M.R., Blum, M., Fasshauer, I., D'Orazio, D., Meyer, U.A. and Wild, D. (1992) The role of the human acetylation polymorphism in the metabolic activation of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ). Carcinogenesis, 13, 1713-1717.
58. Yanagawa, Y., Sawada, M., Deguchi, T., Gonzalez, F.J. and Kamataki, T. (1994) Stable expression of human CYP1A2 and N-acetyltransferases in Chinese hamster CHL cells: mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Res., 54, 3422-3427.
59. Sengstag, C., Eugster, H.-P. and Würgler, F.E. (1994) High promutagen activating capacity of yeast microsomes containing human cytochrome P-450 1A and human NADPH cytochrome P450 reductase. Carcinogenesis, 15, 837-843.
60. Josephy, P.D., DeBruin, L.S., Lord, H.L., Oak, J.N., Evans, D.H., Guo, Z., Dong, M.-S. and Guengerich, F.P. (1995) Bioactivation of aromatic amines by recombinant human cytochrome P4501A2 expressed in Ames tester strain bacteria: a substitute for activation by mammalian tissue preparations. Cancer Res., 55, 799-802.
61. Shimada, T. and Guengerich, F.P. (1991) Activation of amino-a-carboline, 2-amino-1-methyl-6-phenyl-imidazo[4,5-b]pyridine and a copper phthalocyanine cellulose extract of cigarette smoke condensate by cytochrome P-450 enzymes in rat and human liver microsomes. Cancer Res., 51, 5284-5291.
62. Wallin, H., Mikalsen, A., Guengerich, F.P., Ingelman-Sundberg, M., Solberg, K.E., Rossland, O.J. and Alexander, J. (1990) Differential rates of metabolic activation and detoxication of the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by different cytochrome P450 enzymes. Carcinogenesis, 11, 489-492.
63. Edwards, R.J., Murray, B.P., Murray, S., Schulz, T., Neubert, D., Gant, T.W., Thorgeirsson, S.S., Boobis, A.R. and Davies, D.S. (1994) Contribution of CYP1A1 and CYP1A2 to the activation of heterocydic amines in monkeys and human. Carcinogenesis, 15, 829-836.
64. Boobis, A.R., Lynch, A.M., Murray, S., De la Torre, R. Solans, A., Farré, M., Segura, J., Gooderham, N.J. and Davies, D.S. (1994) CYP1A2-catalyzed conversion of dietary heterocyclic amines to their proximate carcinogens is their major route of metabolism in humans. Cancer Res., 54, 89-94.
65. Zhao, K., Murray, S., Davies, D.S., Boobis, A.R. and Gooderham, N.J. (1994) Metabolism of the food-derived mutagen and carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human liver microsomes. Carcinogenesis, 15, 1285-1288.
66. Trottier, Y., Waithe, W.I. and Anderson, A. (1992) The detection of promutagen activation by extracts of cells expressing cytochrome P4501A2 cDNA: preincubation dramatically increases revertant yield in the Ames test. Mutat. Res., 281, 39-45.
67. Lin, D.-X., Lang, N.P. and Kadlubar, F.F. (1995) Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats and mice. Drug Metab. Disp., 23, 518-524.
68. Yamazaki., H., Inui, Y., Wrighton, S.A., Guengerich, F.P. and Shimada, T. (1995) Procarcinogen activation by cytochrome P450 3A4 and 3A5 expressed in Escherichia coli and by human liver microsomes. Carcinogenesis, 16, 2167-2170.
69. Sadrieh, N. and Snyderwine, E.G. (1995) Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis, 16, 1549-1555.
70. Crofts, F.G., Strickland, P.T., Hayes, C.L. and Sutter, T.R. (1997) Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) by human cytochromes P4501B1. Carcinogenesis, 18, 1793-1798.
71. Hellmold, H., Magnusson, M., Pelto-Huikko, M., Rylander, T., Gustaffson, J. and Warner, M. (1998) Identification of CYP2A3 as a major cytochrome P450 enzyme in the female peripubertal rat breast. Mol. Pharmacol., 53, 475-482.
72. Snyderwine, E.G., Wirth, P.J., Roller, P.P., Adamson, R.H., Sato, S. and Thorgeirsson, S.S. (1988) Mutagenicity and in vitro covalent DNA binding of 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis, 9, 411-418.
73. Buonarati, M.H. and Felton, J.S. (1990) Activation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) to mutagenic metabolites. Carcinogenesis, 11, 1133-1138.
74. Buonarati, M.H., Turteltaub, K.W., Shen, N.H. and Felton, J.S. (1990) Role of sulfation and acetylation in the activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine to intermediates which bind DNA. Mutat. Res., 245, 185-190.
75. Turesky, R.J., Lang, N.P., Butler, M.A., Teitel, C.H. and Kadlubar, F.F. (1991) Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis, 12, 1839-1845.
76. Davis, C.D., Schut, H.A.J. and Snyderwine, E.G. (1993) Enzymatic phase activation of the N-hydroxylamines of IQ, MeIQx and PhIP by various organs of monkeys and rats. Carcinogenesis, 14, 2091-2096.
77. Chou, H.-C., Lang, N.P. and Kadlubar, F.F. (1995) Metabolic activation of N-hydroxy arylamines and N-hydroxy heterocyclic amines by human sulfotransferase(s). Cancer Res., 55, 525-529.
78. Ozawa, S., Chou, H.-C., Kadlubar, F.F., Nagata, K., Yamazoe, Y. and Kato, R. (1994) Activation of 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine by cDNA-expressed human and rat arylsulfotransferases. Jpn. J. Cancer Res., 85, 1220-1228.
79. Kaderlik, K.R., Minchin, R.F., Mulder, G.J., Ilett, K.F., Daugaard-Jenson, M., Teitel, C.H. and Kadlubar, F.F. (1994) Metabolic activation pathway for the formation of DNA adducts of the carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in rat extrahepatic tissues. Carcinogenesis, 15, 1703-1709.
80. Minchin, R.F., Reeves, P.T., Teitel, C.H., McManus, M.E., Mojarrabi, B., Ilett, K.F. and Kadlubar, F.F. (1992) N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem. Biophys. Res. Commun., 185, 839-844.
81. Hein, D.W., Rustan, T.D., Ferguson, R.J., Doll, M.A. and Gray, K. (1994) Metabolic activation of aromatic and heterocyclic N-hydroxyarylamines by wild-type and mutant recombinant human NAT1 and NAT2 acetyltransferases. Arch. Toxicol., 68, 129-133.
82. Sadrieh, N., Davis, C.D. and Snyderwine, E.G. (1996) N-acetyltransferase expression and metabolic activation of the food-derived heterocyclic amines in the human mammary gland. Cancer Res., 56, 2683-2687.
83. Davis, C.D., Schut, H.A.J., Adamson, R.H., Thorgeirsson, U.P., Thorgeirsson, S.S. and Snyderwine, E.G. (1993) Mutagenic activation of IQ, PhIP and MeIQx by hepatic microsomes from rat, monkey and man: low mutagenic activation of MeIQx in cynomolgus monkeys in vitro reflects low DNA adduct levels in vivo. Carcinogenesis, 14, 61-65.
84. Snyderwine, E.G., Welti, D.H., Davis, C.D., Fay, L.B. and Turesky, R.J. (1995) Metabolism of the food-derived carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in nonhuman primates. Carcinogenesis, 16, 1377-1384.
85. Snyderwine, E.G., Nouso, K. and Schut, H.A.J. (1993) Effect of 3-methylcholanthrene induction on the distribution and DNA adduction of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in F344 rats. Food Chem. Toxicol., 31, 415-423.
86. Nerurkar, P.V., Schut, H.A.J., Anderson, L.M., Riggs, C.W., Snyderwine, E.G., Thorgeirsson, S.S., Weber, W.W., Rice, J.M. and Levy, G.N. (1995) DNA adducts of 2-amino-3-methylimidazo-[4,5-f]quinoline (IQ) in colon, bladder and kidney of congenic mice differing in Ah responsiveness and N-acetyltransferase genotype. Cancer Res., 55, 3043-3049.
87. Nerurkar, P.V., Schut, H.A.J., Anderson, L.M. et al. (1996) Ahr locus phenotype in congenic mice influences hepatic and pulmonary DNA adduct levels of 2-amino-3-methylimidazo[4,5-f]quinoline in the absence of cytochrome P450 induction. Mol. Pharmacol., 49, 874-881.
88. Lin, D., Meyer, D.J., Ketterer, B., Lang, N.P. and Kadlubar, F.F. (1994) Effects of human and rat glutathione S-transferases on the covalent DNA binding of the N-acetoxy derivatives of heterocyclic amine carcinogens in vitro: a possible mechanism of organ specificity in their carcinogenesis. Cancer Res., 54, 4920-4926.
89. Kaderlik, K.R., Mulder, G.J., Shaddock, J.G., Casciano, D.A., Teitel, C.H. and Kadlubar, F.F. (1994) Effect of glutathione depletion and inhibition of glucuronidation and sulfation on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) metabolism, PhIP-DNA adduct formation and unscheduled DNA synthesis in primary rat hepatocytes. Carcinogenesis, 15, 1711-1716.
90. Ghoshal, A., Davis, C.D., Schut, H.A.J. and Snyderwine, E.G. (1995) Possible mechanisms for PhIP-DNA adduct formation in the mammary gland of female Sprague-Dawley rats. Carcinogenesis, 16, 2725-2731.
91. Aune, T. and Aune, K.T. (1986) Mutagenic activation of IQ and Me-IQ by liver and lung microsomes from rabbit and mouse and with isolated lung cells from the rabbit. Carcinogenesis, 7, 273-276.
92. Holme, J.A., Alexander, J. and Dybing, E. (1987) Mutagenic activation of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) by subcellular fractions and cells isolated from small intestine, kidney and liver of the rat. Cell Biol. Toxicol., 3, 51-61.
93. McKinnon, R.A., Burgess, W.M., Hall, P. de la M., Abdul-Haziz, A. and McManus, M.E. (1992) Metabolism of food-derived heterocyclic amines in human and rabbit tissues by P4503A proteins in the presence of flavonoids. Cancer Res., 52 (suppl.), 2108s-2113s.
94. Hellmold, H., Övervik, E., Strömstedt, M. and Gustafsson, J.-Å. (1993) Cytochrome P450 forms in the rodent lung involved in the metabolic activation of food-derived heterocyclic amines. Carcinogenesis, 14, 1751-1757.
95. Davis, C.D., Ghoshal, A., Schut, H.A.J. and Snyderwine, E.G. (1994) Metabolic activation of heterocyclic amine food mutagens in the mammary gland of lactating Fischer 344 rats. Cancer Lett., 84, 67-73.
96. Pfau, W., O'Hare, M.J., Grover, P.L. and Phillips, D.H. (1992) Metabolic activation of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) to DNA binding species in human mammary epithelial cells. Carcinogenesis, 13, 907-909.
97. Carmichael, P.L., Stone, E.M., Grover, P.L., Gusterson, B.A. and Phillips, D.H. (1996) Metabolic activation and DNA binding of food mutagens and other environmental carcinogens in human mammary epithelial cells. Carcinogenesis, 17, 1769-1772.
98. Lawson, T. and Kolar, C. (1994) Mutagenicity of heterocyclic amines when activated by pancreas tissue. Mutat. Res., 325, 125-128.
99. Butcher, N.J., Minchin, R.F., Kadlubar, F.F. and Ilett, K.F. (1996) Uptake of the food-derived heterocyclic amine carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and its N-hydroxy metabolite into rat pancreatic acini and hepatocytes in vitro. Carcinogenesis, 17, 889-892.
100. Wild, D. and Degen, G.H. (1987) Prostaglandin H synthase-dependent mutagenic activation of heterocyclic aromatic amines of the IQ-type. Carcinogenesis, 8, 541-545.
101. Flammang, T.J., Yamazoe, Y., Benson, R.W., Roberts, D.W., Potter, D.W., Chu, D.Z.J., Lang, N.P. and Kadlubar, F.F. 11989) Arachidonic acid-dependent peroxidative activation of carcinogenic arylamines by extrahepatic human tissue microsomes. Cancer Res., 49, 1977-1982.
102. Petry, T.W., Josephy, P.D., Pagano, D.A., Zeiger, E., Knecht, K.T. and Eling, T.E. (1989) Prostaglandin hydroperoxidase-dependent activation of heterocyclic aromatic amines. Carcinogenesis, 10, 2201-2207.
103. Morrison, L.D., Eling, T.E. and Josephy, P.D. (1993). Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3-methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ. Mutat. Res., 302, 45-52.
104. Anari, M.R., Khan, S., Jatoe, S.D. and O'Brien, P.J. (1997) Cytochrome P450 dependent xenobiotic activation by physiological hydroperoxides in intact hepatocytes. Eur. J. Drug Metab. Pharmacokinet., 22, 305-310.
105. Anari, M.R., Josephy, P.D., Henry, T. and O'Brien, P.J. (1997) Hydrogen peroxide supports human and rat cytochrome P4501A2-catalyzed 2-amino-3-methylimidazo[4,5-f]quinoline bioactivation to mutagenic metabolites: significance of cytochrome P450 peroxygenase. Chem. Res. Toxicol., 10, 582-588.
106. Malfatti, M.A., Connors, M.S., Mauthe, R.J. and Felton, J.S. (1996) The capability of rat colon tissue slices to metabolize the cooked-food carcinogen 2-amino-1-methyl-6-pheylimidazo[4,5-b]pyridine. Cancer Res., 56, 2550-2555.
107. Anderson, K.E., Hammons, G.J., Kadlubar, F.F. et al. (1997) Metabolic activation of aromatic amines by human pancreas. Carcinogenesis, 18, 1085-1092.
108. Snyderwine, E.G., Davis, C.D., Schut, H.A.J. and Roberts-Thomson, S.J. (1998) Proliferation, development and DNA adduct levels in the mammary gland of rats given 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and a high fat diet. Carcinogenesis, 19, 1209-1215.
109. Kadlubar, F.F. and Beland, F.A. (1985) Chemical properties of ultimate carcinogenic metabolites of arylamines and arylamides. In Harvey, R.G. (ed.) Polycyclic Hydrocarbons and Carcinogenesis. American Chemical Society Symposium Series, ACS, Washington, DC, vol. 283, pp. 341-370.
110. Snyderwine, E.G., Roller, P.P., Adamson, R.H., Sato, S. and Thorgeirsson, S.S. (1988) Reaction of N-hydroxylamine and N-acetoxy derivatives of 2-amino-3-methylimidazo[4,5-f]quinoline with DNA. Synthesis and identification of N-(deoxyguanosin-8-yl)-IQ. Carcinogenesis, 9, 1061-1065.
111. Dirr, A. and Wild, D. (1988) Synthesis and mutagenic activity of nitroimidazoarenes. A study on the mechanism of the genotoxicity of heterocyclic arylamines and nitroarenes. Mutagenesis, 3, 147-152.
112. Wild, D. and Dirr, A. (1988) Synthesis of 2-azido-3-methylimidazo[4,5-f]quinoline and photolytic generation of a highly reactive and mutagenic IQ derivative. Carcinogenesis, 9, 869-871.
113. Wild, D., Dirr, A., Fasshauer, I. and Henschler, D. (1989) Photolysis of arylazides and generation of highly electrophilic DNA-binding and mutagenic intermediates. Carcinogenesis, 10, 335-341.
114. Wild, D., Watkins, B.E. and Vanderlaan, M. (1991) Azido- and nitro-PhIP, relatives of the heterocyclic arylamine and food mutagen PhIP-mechanism of their mutagenicity in Salmonella. Carcinogenesis, 12, 1091-1096.
115. Sabbioni, G. and Wild, D. (1992) Quantitative structure-activity relationships of mutagenic aromatic and heteroaromatic azides and amines. Carcinogenesis, 13, 709-713.
116. 2 atoms of guanine. Chem. Res. Toxicol., 5, 479-490.
117. 32P-postlabeling method to detect DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in monkeys fed IQ: identification of the N-(deoxyguanosin-8-yl)-IQ adduct. Carcinogenesis, 9, 1739-1743.
118. 1 mouse, cynomologus monkey and Salmonella typhimurium. Carcinogenesis, 12, 931-934.
119. 2 atoms of guanine. Chem. Res. Toxicol., 7, 752-761.
120. 32P-postlabeling analysis of IQ, MeIQx and PhIP adducts formed in vitro in DNA and polynucleotides and found in vivo in hepatic DNA from IQ-, MeIQx- and PhIP-treated monkeys. Carcinogenesis, 14, 1389-1395.
121. 2-guanine adducts of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in the liver, kidney and colorectum of the rat. Chem. Res. Toxicol., 9, 397-402.
122. Turesky, R.J., Gremaud, E., Markovic, J. and Snyderwine, E.G. (1996) DNA adduct formation of the food-derived mutagen 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates undergoing carcinogen bioassay. Chem. Res. Toxicol., 9, 403-408.
123. 32P-postlabeling analysis. Carcinogenesis, 8, 1589-1593.
124. 32P-postlabeling method. Nucleic Acid Res. Symp. Series, 19, 111-114.
125. 1 mice fed 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethyl-imidazo[4,5-f]quinoline (MeIQ). Carcinogenesis, 11, 1005-1011.
126. Övervik, E., Ochiai, M., Hirose, M., Sugimura, T. and Nagao, M. (1991) The formation of heart DNA adducts in F344 rats following dietary administration of heterocyclic amines. Mutat. Res., 256, 37-43.
127. Kajikawa, A., Umemoto, A., Hamada, K., Tanaka, M., Kinouchi, T., Ohnishi, Y. and Monden, Y. (1995) Mucosa-preferential DNA adduct formation by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat colonic wall. Cancer Res., 55, 2769-2773.
128. Tada, A., Ochiai, M., Wakabayashi, K., Nukaya, H., Sugimura, T. and Nagao, M. (1994) Identification of N-(deoxyguanosin-8-yl)-2-amino-3,4-dimethylimidazo[4,5-f]quinoline (dG-C8-MeIQ) as a major adduct formed by MeIQ with nucleotides in vitro and with DNA in vivo. Carcinogenesis, 15, 1275-1278.
129. 32P-postlabeling method, in the liver of rats fed MeIQx. Carcinogenesis, 14, 2165-2170.
130. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures. Carcinogenesis, 9, 1687-1693.
131. Turteltaub, K.W., Watkins, B.E., Vanderlaan, M. and Felton, J.S. (1990) Role of metabolism on the DNA binding of MeIQx in mice and bacteria. Carcinogenesis, 11, 43-49.
132. Yamashita, K., Adachi, M., Kato, S., Nakagama, H., Ochiai, M., Wakabayashi, K., Sato, S., Nagao, M. and Sugimura, T. (1990) DNA adducts formed by 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in rat liver: dose-response on chronic administration. Jpn. J. Cancer Res., 81, 470-476.
133. Hirose, M., Wakabayashi, K., Ochiai, M., Kushida, H., Sato, H., Sugimura, T. and Nagao, M. (1995) Formation and removal of DNA adducts in the liver of rats chronically fed the food-borne carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Jpn. J. Cancer Res., 86, 516-522.
134. 2-(2′-deoxyguanosin-8-yl)-4,8-DiMeIQx adduct. Carcinogenesis, 15, 2553-2558.
135. 32P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methy-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure. Chem. Res. Toxicol., 9, 1050-1056.
136. 2-(2′-deoxyguanosin-8-yl)-PhIP. Carcinogenesis, 13, 629-635.
137. Lin, D., Kaderlik, K.R., Turesky, R.J., Miller, D.W., Lay, J.O. Jr and Kadlubar, F.F. (1992) Identification of N-(deoxyguanosin-8-yl)-2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine as the major adduct formed by the food-borne carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, with DNA. Chem. Res. Toxicol., 5, 691-697.
138. Nagoaka, H., Wakabayashi, K., Kim, S.-B. et al. (1992) Adduct formation at C8 of guanine on in vitro reaction of the ultimate form of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine with 2′-deoxyguanosine and its phosphate esters. Jpn. J. Cancer Res., 83, 1025-1029.
139. Takayama, K., Yamashita, K., Wakabayashi, K., Sugimura, T. and Nagao, M. (1989) DNA modification by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in rats. Jpn. J. Cancer Res., 80, 1145-1148.
140. Schut, H.A.J. and Herzog, C.R. (1992) Formation of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in male Fischer-344 rats. Cancer Lett., 67, 117-124.
141. Turteltaub, K.W., Frantz, C.E., Creek, M.R., Vogel, J.S., Shen, N. and Fultz, E. (1993) DNA adducts in model systems and humans. J. Cell. Biochem., 17F (suppl.), 138-148.
142. 32P-postlabeling analysis of DNA adducts formed by food-derived heterocyclic amines: evidence for incomplete hydrolysis and a procedure for adduct pattern simplification. Carcinogenesis, 15, 877-882.
143. 32P-postlabeling method. Jpn. J. Cancer Res., 85, 113-117.
144. Marsch, G.A., Goldman, E.N., Fultz, E., Shen, N.H. and Turteltaub, K.W. (1995) Heterogeneous DNA adduct formation in vitro by the acetylated food mutagen 2-(acetoxyamino)-1-methyl-6-phenylimidazo[4,5-b]-pyridine: a fluorescence spectroscopic study. Chem. Res. Toxicol., 8, 659-670.
145. Wakabayashi, K., Nagao, M., Esumi, H. and Sugimura, T. (1992) Food-derived mutagens and carcinogens. Cancer Res., 52 (Suppl.), 2092s-2098s.
146. Felton, J.S., Knize, M.G., Dolbeare, F.A. and Wu, R. (1994) Mutagenic activity of heterocyclic amines in cooked foods. Environ. Health Perspect., 102 (suppl. 6), 201-204.
147. Alldrick, A.J., Lake, B.G., Flynn, J. and Rowland, I.R. (1986) Metabolic conversion of IQ and MeIQ to bacterial mutagens. Mutat. Res., 163, 109-114.
148. Kerdar, R.S., Dehner, D. and Wild, D. (1993) Reactivity and genotoxicity of arylnitrenium ions in bacterial and mammalian cells. Toxicol. Lett., 67, 73-85.
149. Malfatti, M.A., Shen, N.H., Wu, R.W., Turteltaub, K.W. and Felton, J.S. (1995) A correlation of Salmonella mutagenicity with DNA adducts induced by the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mutagenesis, 10, 425-431.
150. Wild, D. and Dirr, A. (1988) Mutagenic nitrenes/nitrenium ions from azidoimidazoarenes and their structure-activity relationships. Mutagenesis, 4, 446-452.
151. Hatch, F.T. and Colvin, M.E. (1977) Quantitative structure-activity (QSAR) relationships of mutagenic aromatic and heterocyclic amines. Mutat. Res., 376, 87-96.
152. Ford, G.P. and Griffin, G.R. (1992) Relative stabilities of nitrenium ions derived from heterocyclic amine food-carcinogens: relationship to mutagenicity. Chem. Biol. Interact., 81, 19-33.
153. Saito, K., Shinohara, A., Kamataki, T. and Kato, R. (1985) Metabolic activation of mutagenic N-hydroxyarylamines by O-acetyltransferase in Salmonella typhimurium TA98. Arch. Biochem. Biophys., 239, 286-295.
154. Wild, D., Feser, W., Michel, S., Lord, H.L. and Josephy, P.D. (1995) Metabolic activation of heterocyclic aromatic amines catalyzed by human arylamine N-acetyltransferase isozymes (NAT1 and NAT2) expressed in Salmonella typhimurium. Carcinogenesis, 16, 643-648.
155. Suzuki, A., Kushida, H., Iwata, H., Watanabe, M., Nohmi, T., Fujita, Gonzalez, F.J. and Kamataki, T. (1998) Establishment of Salmonella tester strain highly sensitive to mutagenic heterocyclic amines. Cancer Res., 58, 1833-1838.
156. Koch, W.H., Wu, R.W., Cebula, T.A. and Felton, J.S. (1998) Specificity of base substitution mutations induced by the dietary carcinogens 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in Salmonella. Environ. Mol. Mutagen., 31, 327-332.
157. Fuscoe, J.C., Wu, R., Shen, N.H., Healy, S.K. and Felton, J.S. (1988) Base-change analysis of revertants of the hisD3052 allele in Salmonella typhimurium. Mutat. Res., 201, 241-251.
158. Watanabe, M. and Ohta, T. (1993) Analysis of mutational specificity induced by heterocyclic amines in the lacZ gene of Escherichia coli. Carcinogenesis, 14, 1149-1153.
159. Kosakam, P., Halliday, J.A., Glickman, B.W. and Josephy, P.D. (1993) Mutational specificity of 2-nitro-3,4-dimethylimidazo[4,5-f]quinoline in the lacI gene of Escherichia coli. Carcinogenesis, 14, 511-517.
160. Solomon, M.S., Morgenthaler, P.-M.L., Turesky, R.J. and Essigmann, J.M. (1996) Mutational and DNA binding specificity of the carcinogen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. J. Biol. Chem., 271, 18368-18374.
161. Endo, H., Schut, H.A.J. and Snyderwine, E.G. (1995) Distribution of the DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine in the supF gene as determined by polymerase arrest assay. Mol. Carcinogen., 14, 198-204.
162. Aeschbacher, H.-A. and Turesky, R.J. (1991) Mammalian cell mutagenicity and metabolism of heterocyclic aromatic amines. Mutat. Res., 259, 235-250.
163. Thompson, L.H., Carrano, A.V. Salazar, E., Felton, J.S. and Hatch, F.T. (1983) Comparative genotoxic effects of the cooked-food-related mutagens Trp-P-2 and IQ in bacteria and cultured mammalian cells. Mutat. Res., 117, 243-257.
164. Brookman, K.W., Salazar, E.P. and Thompson, L.H. (1985) Comparative mutagenic efficiencies of the DNA adducts from the cooked-food-related mutagens Trp-P-2 and IQ in CHO cells. Mutat. Res., 149, 249-255.
165. Holme, J.A., Hongslo, J.K., Soderlund, E.J., Brunborg, G., Christensen, T., Alexander, J. and Dybing, E. (1987) Comparative genotoxic effects of IQ and MeIQ in Salmonella typhimurium and cultured mammalian cells. Mutat. Res., 187, 181-190.
166. Thompson, L.H., Tucker, J.D., Stewart, S.A., Christensen, M.L., Salazar, E.P., Carrano, A.V. and Felton, J.S. (1987) Genotoxicity of compounds from cooked beef in repair-deficient CHO cells versus Salmonella mutagenicity. Mutagenesis, 2, 483-487.
167. Howes, A.J., Beamand, J.A. and Rowland, I.R. (1986) Induction of unscheduled DNA synthesis in rat and hamster hepatocytes by cooked food mutagens. Food Chem. Toxicol., 24, 383-387.
168. Yoshimi, N., Sugie, S., Iwata, H., Mori, H. and Williams, G. (1988) Species and sex differences in genotoxicity of heterocyclic amine pyrolysis and cooking products in the hepatocyte primary culture/DNA repair test using rat, mouse and hamster hepatocytes. Environ. Mol. Mutagen., 12, 53-64.
169. Aeschbacher, H.U. and Ruch, E. (1989) Effect of heterocyclic amines and beef extract on chromosome aberrations and sister chromatid exchanges in cultured human lymphocytes. Carcinogenesis, 10, 429-433.
170. Buonarati, M.H., Tucker, J.D., Minkler, J.L., Wu, R.W., Thompson, L.H. and Felton, J.S. (1991) Metabolic activation and cytogenetic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in Chinese hamster ovary cells expressing murine cytochrome P450 IA2. Mutagenesis, 6, 253-259.
171. Rodrigues, A.S., Silva, I.D., Caria, M.H., Laires, A., Chaveca, T., Glatt, H.R. and Rueff, J. (1994) Genotoxicity assessment of aromatic amines and amides in genetically engineered V79 cells. Mutat. Res., 341, 93-100.
172. Kitazawa, T., Kominami, R., Tanaka, R., Wakabayashi, K. and Nagao, M. (1994) 2-Hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine induction of recombinational mutations in mammalian cell lines as detected by DNA fingerprinting. Mol. Carcinogen., 9, 67-70.
173. Fan, L. and Snyderwine, E.G. (1994) Inhibition of plasmid reporter gene expression in CHO cells by DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo-(4,5-b]pyridine. Mol. Carcinogen., 10, 30-37.
174. Endo, H., Schut, H.A.J. and Snyderwine, E.G. (1994) Mutagenic specificity of 2-amino-3-methylimidazo[4,5-f]quinoline and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the supF shuttle vector system. Cancer Res., 54, 3745-3751.
175. Carothers, A.M., Yuan, W., Hingerty, B.E., Broyde, S., Grunberger, D. and Snyderwine, E.G. (1994) Mutation and repair induced by the carcinogen 2-(hydroxyamino)-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP) in the dihydrofolate reductase gene of Chinese hamster ovary cells and conformational modeling of the dG-C8-PhIP adduct in DNA. Chem. Res. Toxicol., 7, 209-218.
176. Morgenthaler, P.-M.L. and Holzhauser, D. (1995) Analysis of mutations induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in human lymphoblastoid cells. Carcinogenesis, 16, 713-718.
177. Wu, R.W., Wu, E.M., Thompson, L.H. and Felton, J.S. (1995) Identification of aprt gene mutations induced in repair-deficient and P450-expressing CHO cells by the food-related mutagen/carcinogen, PhIP. Carcinogenesis, 16, 1207-1213.
178. Lee, H. and Shih, M.-K. (1995) Mutational specificity of 2-amino-3-methylimidazo[4,5-f]quinoline in the hprt locus of CHO-K1 cells. Mol. Carcinogen., 13, 122-127.
179. Otsuka, C., Miura, K.F. and Ishidate, M. Jr (1996) The possible role of acetyltransferase in the induction of cytogenetic effects by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in cultured Chinese hamster cells. Mutat. Res., 371, 23-28.
180. Yadollahi-Farsani, M., Gooderham, N.J., Davies, D.S. and Boobis, A.R. (1996) Mutational spectra of the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) at the Chinese hamster hprt locus. Carcinogenesis, 17, 617-624.
181. Otsuka, C., Miura, K.F., Satoh, T., Hatanaka, M., Wakabayashi, K. and Ishidate, M. Jr (1996) Cytogenetic effects of a food mutagen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and its metabolite, 2-hydroxyamino-1-methyl-6-phenylimidazo[4,5-b]pyridine (N-OH-PhIP), on human and Chinese hamster cells in vitro. Mutat. Res., 367, 115-121.
182. Shibutani, S., Fernandes, A., Suzuki, N., Tan, X., Johnson, F. and Grollman, A.P. (1998) Site-specific mutagenesis studies of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-derived DNA adduct in mammalian cells. In Proceedings of the International Workshop on Heterocyclic Aromatic Amines, Graz, Austria, April 23-24.
183. Minkler, J.L. and Carrano, A.V. (1984) In vivo cytogenetic effects of the cooked-food-related mutagens Trp-P-2 and IQ in mouse bone marrow. Mutat. Res., 140, 49-53.
184. Tucker, J.D., Carrano, A.V., Allen, N.A., Christensen, M.L., Knize, M.G., Strout, C.L. and Felton, J.S. (1989) In vivo cytogenetic effects of cooked food mutagens. Mutat. Res., 224, 105-113.
185. Director, A.E., Nath, J., Ramsey, M.J., Swiger, R.R. and Tucker, J.D. (1996) Cytogenetic analysis of mice chronically fed the food mutagen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine Mutat. Res., 359, 53-61.
186. Breneman, J.W., Briner, J.F., Ramsey, M.J., Director, A. and Tucker, J.D. (1996) Cytogenetic results from a chronic feeding study of MeIQx in mice. Food Chem. Toxicol., 34, 717-724.
187. Suzuki, T., Hayashi, M., Ochiai, M., Wakabayashi, K., Ushijima, T., Sugimura, T., Nagao, M. and Sofuni, T. (1996) Organ variation in the mutagenicity of MeIQ in Big Blue lacI transgenic mice. Mutat. Res., 369, 45-49.
188. Ushijima, T., Hosoya, Y., Ochiai, M. et al. (1994) Tissue-specific mutational spectra of 2-amino-3,4-dimethylimidazo[4,5-f]quinoline in the liver and bone marrow of lacI transgenic mice. Carcinogenesis, 15, 2805-2809.
189. Davis, C.D., Dacquel, E.J., Schut, H.A.J., Thorgeirsson, S.S. and Snyderwine, E.G. (1996) In vivo mutagenicity and DNA adduct levels of heterocyclic amines in Muta™ mice and c-myc/lacZ double transgenic mice. Mutat. Res., 356, 287-296.
190. Lynch, A.M., Gooderham, N.J. and Boobis, A.R. (1996) Organ distinctive mutagenicity in Muta™ mouse after short-term exposure to PhIP. Mutagenesis, 11, 505-509.
191. Zhang, X.B., Felton, J.S., Tucker, J.D., Urlando, C. and Heddle, J.A. (1996) Intestinal mutagenicity of two carcinogenic food mutagens in transgenic mice: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and amino[a]-carboline. Carcinogenesis, 17, 2259-2265.
192. Okonogi, H., Ushijima, T., Zhang, X.B. et al. (1997) Agreement of mutational characteristics of heterocyclic amines in lacI of the Big Blue mouse with those in tumor related genes in rodents. Carcinogenesis, 18, 745-748.
193. Ryu, D.-Y., Weider, V.S., Davis, C.D., Schut, H.A.J., Thorgeirsson, S.S. and Snyderwine, E.G. (1998) In vivo mutagenicity and hepatocarcinogenicity of MeIQx in transgenic C57B1/lacZ (MutaMice) and double transgenic c-myc/lacZ mice. Proc. Am. Assoc. Cancer Res., 39, 633.
194. Bird, R.P. and Bruce, W.R. (1984) Damaging effect of dietary components to colon epithelial cells in vivo: effect of mutagenic heterocyclic amines. J. Natl. Cancer Inst., 73, 237-240.
195. Dolara, P., Caderni, G., Bianchini, F. and Tanganelli, E. (1986) Nuclear damage of colon epithelial cells by the food carcinogen 2-amino-3-methyimidazo[4,5-f]quinoline (IQ) is modulated by dietary lipids. Mutat. Res., 175, 255-258.
196. Bird, R.P. and Bruce, W.R. (1986) Effect if dietary fat levels on the susceptibility of colonic cells to nuclear-damaging agents. Nutr. Cancer, 8, 93-100.
197. Brooks, R.A., Gooderham, N.J., Zhao, K. Edwards, R.J., Howard, L.A., Boobis, A.R. and Winton, D.J. (1994) 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine is a potent mutagen in the mouse small intestine. Cancer Res., 54, 1665-1671.
198. Winton, D.J., Gooderham, N.J., Boobis, A.R., Davies, D.S. and Ponder, B.A.J. (1990) Mutagenesis of mouse intestine in vivo using the Dlb-1 specific locus test: studies with 1,2-dimethylhydrazine, dimethylnitrosamines and the dietary mutagen 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. Cancer Res., 50, 7992-7996.
199. Knasmuller, S., Kienzl, H., Huber, W. and Schulte-Hermann, R. (1992) Organ-specific distribution of genotoxic effects in mice exposed to cooked food mutagens. Mutagenesis, 7, 235-241.
200. Santoni-Rugiu, E., Jensen, M.R. and Thorgeirsson, S.S. (1998) Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. Cancer Res., 58, 123-134.
201. Thorgeirsson, S.S., Davis, C.D., Schut, H.A.J., Adamson, R.H. and Snyderwine, E.G. (1995) Possible relationship between tissue distribution of DNA adducts and genotoxicity of food-derived heterocyclic amines. In Adamson, R.H., Gustafsson, J.-Å., Ito, N., Nagao, M., Sugimura, T., Wakabayashi, K. and Yamazoe, Y. (eds) Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens. Princeton Scientific Publishing Co., Princeton, NJ, pp. 85-92.
202. Adamson, R.H., Takayama, S., Sugimura, T. and Thorgeirsson, U.P. (1994) Induction of hepatocellular carcinoma in nonhuman primates by the food mutagen 2-amino-3-methylimidazo-[4,5-f]quinoline. Environ. Health Perspect., 102, 190-193.
203. Schut, H.A.J., Putman, K.L. and Randerath, K. (1988) DNA adduct formation of the carcinogen 2-amino-3-methylimidazo[4,5-f)quinoline in target tissues of the F-344 rat. Cancer Lett., 41, 345-352.
204. Zu, H.-X. and Schut, H.A.J. (1991) Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline in male Fischer-344 rats. Cancer Res., 51, 5636-5641.
205. Schut, H.A.J., Herzog, C.R. and Cummings, D.A. (1994) Accumulation of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in tissues and white blood cells of the Fischer-344 rat after multiple oral dosing. Carcinogenesis, 15, 1467-1470.
206. 1 mice. Carcinogenesis, 12, 2163-2168.
207. Cummings, D.A. and Schut, H.A.J. (1994) Removal of DNA adducts of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in the male Fischer-344 rat. Carcinogenesis, 15, 2623-2628.
208. He, Y.H., Smale, M.H.E. and Schut, H.A.J. (1997) Chemopreventive properties of indole-3-carbinol: inhibition of DNA adduct formation of the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in female F344 rats. J. Cell. Biochem., 27 (suppl.), 42-51.
209. Snyderwine, E.G., Schut, H.A.J., Sugimura, T., Nagao, M. and Adamson, R.H. (1994) DNA adduct levels of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in tissues of cynomolgus monkeys after single or multiple dosing. Carcinogenesis, 15, 2757-2761.
210. 32P-postlabeling. Chem. Res. Toxicol., 7, 733-739.
211. Friesen, M.D., Cummings, D.A., Garren, L., Butler., R., Bartsch, H. and Schut, H.A.J. (1996) Validation in rats of two biomarkers of exposure to the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP): PhIP-DNA adducts and urinary PhIP. Carcinogenesis, 17, 67-72.
212. Ochiai, M., Watanbe, M., Kushida, H., Wakabayashi, K., Sugimura, T. and Nagao, M. (1996) DNA adduct formation, cell proliferation and aberrant crypt focus formation induced by PhIP in male and female rat colon with relevance to carcinogenesis. Carcinogenesis, 17, 95-98.
213. Kato, T., Hasegawa, R., Nakae, D. et al. (1996) Dose-dependent induction of 8-hydroxyguanine and preneoplastic foci in rat liver by a food-derived carcinogen, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline, at low dose levels. Jpn. J. Cancer Res., 87, 127-133.
214. Nagao, M., Wakabayashi, K., Ushijima, T., Toyota, M., Totsuka, Y. and Sugimura, T. (1996) Human exposure to carcinogenic heterocyclic amines and their mutational fingerprints in experimental animals. Environ. Health Perspect., 104 (suppl. 3), 497-501.
215. Nagao, M., Ushijima, T. Wakabayashi, K., Ochiai, M., Kushida, H., Sugimura, T., Hasegawa, R., Shirai, T. and Ito, N. (1994) Dietary carcinogens and mammary carcinogenesis. Cancer, 74, 1063-1069.
216. Toyota, M., Ushijima, T., Kakiuchi, H., Canzian, F., Watanabe, M., Imai, K., Sugimura, T. and Nagao, M. (1996) Genetic alterations in rat colon tumors induced by heterocyclic amines. Cancer, 77, 1593-1597.
217. Ushijima, T., Kakiuchi, H., Makino, H. et al. (1994) Infrequent mutation of Ha-ras and p53 in rat mammary carcinomas induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Mat. Carcinogen., 10, 38-44.
218. Makino, H., Ishizaka, Y., Tsujimoto, A., Nakamura, T., Onda, M., Sugimura, T. and Nagao, M. (1992) Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo-[4,5-f]quinoline, a food mutagen. Proc. Natl Acad. Sci. USA, 89, 4850-4854.
219. Makino, H., Ushijima, T., Kakiuchi, H., Onda, M., Ito, N., Sugimura, T. and Nagao, M. (1994) Absence of p53 mutations in rat colon tumors induced by 2-amino-6-methyldipyrido[1,2-a:3′,2′-d]imidazole, 2-amino-3-methylimidazo-[4,5-f]quinoline, or 2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine. Jpn. J. Cancer Res., 85, 510-514.
220. Ushijima, T., Makino, H., Okonogi, H., Hosoya, Y., Sugimura, T. and Nagao, M. (1995) Mutation, loss of heterozygosity and recombination of the p53 gene in mouse forestomach tumors induced by 2-amino-3,4-dimethylimidazo-[4,5-f]quinoline. Mol. Carcinogen., 12, 23-30.
221. Fujimoto, Y., Hampton, L., Snyderwine, E.G., Nagao, M., Sugimura, T., Adamson, R.H. and Thorgeirsson, S.S. (1994) p53 gene mutation in hepatocellular carcinoma induced by 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates. Jpn. J. Cancer Res., 85, 506-509.
222. Kudo, M., Ogura, T., Esumi, H. and Sugimura, T. (1991) Mutational activation of c-Ha-ras gene in squamous cell carcinomas of rat Zymbal gland induced by carcinogenic heterocyclic amines. Mol. Carcinogen., 4, 36-42.
223. 1 mouse. Mol. Carcinogen., 3, 202-207.
224. Takahashi, M., Minamoto, T., Sugimura, T. and Esumi, H. (1993) High frequency and low specificity of ras gene mutations in rat Zymbal's gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline. Carcinogenesis, 14, 1355-1357.
225. Makino, H., Ochiai, M., Caignard, A., Ishizaka, Y., Onda, M., Sugimura, T. and Nagao, M. (1992) Detection of a Ha-ras point mutation by polymerase chain reaction-single strand conformation polymorphism analysis in 2-amino-3,4-dimethylimidazo[4,5-f]quinoline-induced mouse forestomach tumors. Cancer Lett., 62, 115-121.
226. Kakiuchi, H., Ushijima, T., Ochiai, M., Imai, K., Ito, N., Yachi, A., Sugimura, T. and Nagao, M. (1993) Rare frequency of activation of the Ki-ras gene in rat colon tumors induced by heterocyclic amines: possible alternative mechanism of human colon carcinogenesis. Mol. Carcinogen., 8, 44-18.
227. Tachino, N., Hayashi, R., Liew, C., Bailey, G. and Dashwood, R. (1995) Evidence for ras gene mutation in 2-amino-3-methylimidazo[4,5-f]quinoline-induced colonic aberrant crypts in the rat. Mol. Carcinogen., 12, 187-192.
228. Roberts-Thomson, S.J. and Snyderwine, E.G. (1997) Effect of dietary fat on codon 12 and 13 Ha-ras gene mutations in 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced rat mammary gland tumors. Mol. Carcinogen., 20, 348-354.
229. Kakiuchi, H., Watanabe, M., Ushijima, T., Toyota, M., Imai, K., Weisburger, J.H., Sugimura, T. and Nagao, M. (1995) Specific 5′-GGGA-3′→5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. Proc. Natl Acad. Sci. USA, 92, 910-914.
230. Dashwood, R.H., Suzui, M., Nakagama, H., Sugimura, T. and Nagao, M. (1998) High frequency of B-catenin (Ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat. Cancer Res., 58, 1127-1129.
231. Nagao, M., Ushijima, T., Toyota, M., Inoue, R. and Sugimura, T. (1997) Genetic changes induced by heterocyclic amines. Mutat. Res., 376, 161-167.
232. Adamson, R.H., Snyderwine, E.G., Thorgeirsson, U.P., Schut, H.A.J., Turesky, R.J., Thorgeirsson, S.S., Takayama, S. and Sugimura, T. (1991) Metabolic processing and carcinogenicity of heterocyclic amines in nonhuman primates. In Ernster, L. et al. (eds) Xenobiotics and Cancer: Implications of Chemical Carcinogenesis and Cancer Chemotherapy. Japan Scientific Societies Press, Tokyo, pp. 289-301.
233. Thorgeirsson, U.P., Farb, A., Virmani, R. and Adamson, R.H. (1994) Cardiac damage induced by 2-amino-3-methylimidazo[4,5-f]quinoline in nonhuman primates. Environ. Health Perspect., 102, 194-199.
234. Davis, C.D., Farb, A., Thorgeirsson, S.S., Virmani, R. and Snyderwine, E.G. (1994) Cardiotoxicity of heterocyclic amine food mutagens in cultured myocytes and in rats. Toxicol. Appl. Pharmacol., 124, 201-211.
235. Takahashi, S., Imaida, K., Shirai, T., Wakabayashi, K., Nagao, M., Sugimura, T. and Ito, N. (1996) Chronic administration of the mutagenic heterocyclic amine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine induces cardiac damage with characteristic mitochondrial changes in Fischer rats. Toxicol. Pathol., 24, 273-277.
236. Davis, C.D., Schut, H.A.J. and Snyderwine, E.G. (1994). Adduction of the heterocyclic amine food mutagens IQ and PhIP to mitochondrial and nuclear DNA in the liver of Fischer-344 rats. Carcinogenesis, 15, 641-645.
237. Davis, C.D. and Snyderwine, E.G. (1995) Protective effect of N-acetylcysteine against heterocyclic amine induced Cardiotoxicity in cultured myocytes and in rats. Food Chem. Toxicol., 33, 641-651.
238. Maeda, H., Sato, K. and Akaike, T. (1995) Superoxide radical generation from heterocyclic amines. In Adamson, R.H., Gustafsson, J.-A., Ito, N., Nagao, M., Sugimura, T., Wakabayashi, K. and Yamazoe, Y. (eds) Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens. Princeton Scientific Publishing Co., Princeton, NJ. pp. 103-112.
239. Hayatsu, H., Negishi, T. and Arimoto, S. (1993) Dietary inhibitors against mutagenesis and carcinogenesis. In Bronzetti, G., Hayatsu, H., DeFlora, S., Waters, M.D. and Shankel, D.M. (eds) Antimutagenesis and Anticarcinogenesis Mechanisms III. Basic Life Sciences, vol. 61. Plenum Press, New York, NY, pp. 387-418.
240. Snyderwine, E.G. (1994) Some perspectives on the nutritional aspects of breast cancer research. Cancer, 74, 1070-1077.
241. Malaveille, C., Hautefeuille, A., Brun, G., Vincis, P. and Bartsch, H. (1992) Substances in human urine that strongly inhibit bacterial mutagenicity of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and related heterocyclic amines. Carcinogenesis, 13, 2317-2320.
242. Dashwood, R.H. (1992) Protection by chlorophyllin against the covalent binding of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) to rat liver DNA. Carcinogenesis, 13, 113-118.
243. Dashwood, R.H. and Guo, D. (1992) Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-DNA binding by chlorophyllin: studies of enzyme inhibition and molecular complex formation. Carcinogenesis, 13, 1121-1126.
244. Guo, D. and Dashwood, R. (1994) Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ)-DNA binding in rats given chlorophyllin: dose-response and time-course studies in the liver and colon. Carcinogenesis, 15, 763-766.
245. Hernaez, J., Xu, M. and Dashwood, R. (1997) Effects of tea and chlorophyllin on the mutagenicity of N-hydroxy-IQ: studies of enzyme inhibition, molecular complex formation and degradation/scavenging of the active metabolites. Environ. Mol. Mutagen., 30, 468-474.
246. Yun, C-H., Jeong, H.G., Jhoun, J.W. and Guengerich, F.P. (1995) Nonspecific inhibition of cytochrome P450 activities by chlorophyllin in human and rat liver microsomes. Carcinogenesis, 16, 1437-1440.
247. Guo, D., Schut, H.A.J., Davis, C.D., Snyderwine, E.G., Bailey, G.S. and Dashwood, R.H. (1995) Protection by chlorophyllin and indole-3-carbinol against 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis, 16, 2931-2937.
248. 1 mice by heat-altered derivatives of linoleic acid. Food Chem. Toxicol., 30, 9-16.
249. Liew, C., Schut, H.A.J., Chin, S.F. Pariza, M.W. and Dashwood, R.H. (1995) Protection by conjugated linoleic acids against 2-amino-3-methylimidazo[4,5-f]quinoline-induced colon carcinogenesis in the F344 rat: a study of inhibitory mechanisms. Carcinogenesis, 16, 3037-3043.
250. Schut, H.A.J., Cummings, D.A., Smale, M.H.E., Josyula, S. and Friesen, M.D. (1997) DNA adducts of heterocyclic amines: formation, removal and inhibition by dietary components. Mutat. Res., 376, 187-194.
251. Schut, H.A.J. (1993) Effects of dietary menhaden oil on DNA adducts of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in Fischer-344 rats. Anticancer Res., 13, 1517-1524.
252. Schut, H.A.J., Wang, C.-L. Twining, L.M. and Earle, K.M. (1997) Formation and persistence of DNA adducts of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in CDF1 mice fed a high omega-3 fatty acid diet. Mutat. Res., 378, 23-30.
253. Josyula, S. and Schut, H.A.J. (1999) Dietary omega-3 fatty acids as potential inhibitors of carcinogenesis: effect on DNA adduct formation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in mice and rats. Food Chem. Toxicol., in press.
254. Xu, M., Bailey, A.C., Hernaez, J.F., Taoka, C.R., Schut, H.A.J. and Dashwood, R.H. (1996) Protection by green tea, black tea and indole-3-carbinol against 2-amino-3-methylimidazo(4,5-f]quinoline-induced DNA adducts and colonic aberrant crypts in the F344 rat. Carcinogenesis, 17, 1429-1434.
255. Xu, M., Schut, H.A.J., Bjeldanes, L.F., Williams, D.E., Bailey, G.S. and Dashwood, R.H. (1997) Inhibition of 2-amino-3-methylimidazo[4,5-f]quinoline-DNA adducts by indole-3-carbinol: dose-response studies in the rat colon. Carcinogenesis, 18, 2149-2153.
256. 1 mice. Carcinogenesis, 16, 2523-2529.
257. Guo, D., Horio, D.T., Grove, J.S. and Dashwood, R.H. (1995) Inhibition by chlorophyllin of 2-amino-3-methylimidazo[4,5-f]quinoline-induced tumorigenesis in the male F344 rat. Cancer Lett., 95, 161-165.
258. Knasmüller, S., Friesen, M.D., Holme, J.A., Alexander, J., Sanyal, R., Kassie, F. and Bartsch, H. (1996) Effects of phenethyl isothiocyanate on metabolism and on genotoxicity of dimethylnitrosamine and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). Mutat. Res., 350, 93-102.
259. Nelson, R.L. (1992) Chlorophyllin, an antimutagen, acts as a tumor promoter in the rat-dimethylhydrazine colon carcinogenesis model. Anticancer Res., 12, 737-740.
260. Pence, B.C., Buddingh, F. and Yang, S.P. (1986) Multiple factors in the enhancement of dimethylhydrazine carcinogenesis: main effect of indole-3-carbinol. J. Natl Cancer Inst., 77, 269-276.
261. Kim, D.J., Han, B.S., Ahn, B., Hasegawa, R., Shirai, T., Ito, N. and Tsuda,H. (1997) Enhancement by indole-3-carbinol of liver and thyroid gland neuplastic development in a rat medium-term multi-organ carcinogenesis model. Carcinogenesis, 18, 377-381.
262. Hasegawa, R., Hirose, M., Kato, T., Hagiwara, A., Boonyaphiphat, P., Nagao, M., Ito, N. and Shirai, T. (1995) Inhibitory effect of chlorophyllin on PhIP-induced mammary carcinogenesis in female F344 rats. Carcinogenesis, 16, 2243-2246.
263. Reddy, B.S. and Rivenson, A. (1993) Inhibitory effect of Bifidobacterium longum on colon, mammary and liver carcinogenesis induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Cancer Res., 53, 3914-3918.
264. Weisburger, J.H., Rivenson, A., Hard, G.C., Zang, E., Nagao, M. and Sugimura, T. (1994) Role of fat and calcium in cancer causation by food mutagens, heterocyclic amines. Proc. Soc. Exp. Biol. Med., 205, 347-352.
265. Tsuda, H., Uehara, N., Iwahori, Y., Asamoto, M., Iigo, M., Nagao, M., Matsumoto, K., Ito, M. and Hirono, I. (1994) Chemopreventive effects of β-carotene, α-tocopherol and live naturally occurring antioxidants on initiation of hepato-carcinogenesis by 2-amino-3-methylimidazo[4,5-f]quinoline in the rat. Jpn. J. Cancer Res., 85, 1214-1219.
266. Hirose, M., Akagi, K., Hasegawa, R., Yaono, M., Satoh, T., Hara, Y., Wakabayashi, K. and Ito, N. (1995) Chemoprevention of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants in F344 female rats. Carcinogenesis, 16, 217-221.
267. Hirose, M., Hasegawa, R., Kimura, J. et al. (1995) Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3c,2c-d]imidazole (Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependent inhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis, 16, 3049-3055.
268. Schut, H.A.J. and Shiverick, K.T. (1992) DNA adducts in humans as dosimeters of exposure to environmental, occupational, or dietary genotoxins. FASEB J., 6, 2942-2951.
269. 2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (dG-C8-MeIQx) in human tissues. Carcinogenesis, 17, 1029-1034.
270. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis, 7, 1543-1551.
271. Turteltaub, K.W., Felton, J.S., Gledhill, B.L. et al. (1990) Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. Proc. Natl Acad. Sci. USA, 87, 5288-5292.
272. 32P-postlabeling. In Adamson, R.H., Gustafsson, J.-A., Ito, N., Nagao, M., Sugimura, T., Wakabayashi, K. and Yamazoe, Y. (eds) Heterocyclic Amines in Cooked Foods: Possible Human Carcinogens. Princeton Scientific Publishing Co., Princeton, NJ, pp. 93-162.
273. Turteltaub, K.W., Vogel, J.S., Frantz, C. and Shen, N. (1992) Fate and distribution of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in mice at a human dietary equivalent dose. Cancer Res., 52, 4682-4687.
274. Frantz, C.E., Bangerter, C., Fultz, E., Mayer, K.M., Vogel, J.S. and Turteltaub, K.W. (1995) Dose-response studies of MeIQx in rat liver and liver DNA at low doses. Carcinogenesis, 16, 367-373.
275. Mauthe, R.J., Dingley, K.H., Freeman, S.P. and Turteltaub, K.W. (1997) Dose-response and clearance rate of low dose PhIP exposures in rats. Proc. Am. Assoc. Cancer Res., 38, 466.
276. Mauthe, R.J., Snyderwine, E.G., Ghoshal, A., Freeman, S.P.H.T. and Turteltaub, K.W. (1998) Distribution and metabolism of 2-amino-1 -methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in female rats and their pups at dietary doses. Carcinogenesis, 19, 919-924.
277. Willett, W.C., Stampfer, M.J., Colditz, G.A., Rosner, B.A. and Speizer, F.E. (1990) Relation of meat, fat and fiber intake to the risk of colon cancer in a prospective study among women. N. Engl. J. Med., 323, 1664-1672.
278. Giovannucci, E., Stampfer, M.J., Colditz, G., Rimm, E.B. and Willett, W.C. (1992) Relationship of diet to risk of colorectal adenoma in men. J. Natl Cancer Inst., 84, 91-98.
279. Gerhardsson de Verdier, M., Hagman, U., Peters, R.K., Steineck, G. and Överik, E. (1991) Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int. J. Cancer, 49, 1-6.
280. Steineck, G., Gerhardsson de Verdier, M. and Överik, E. (1993) The epidemiological evidence concerning intake of mutagenic activity from the fried surface and the risk of cancer cannot justify preventive measures. Eur. J. Cancer Prevent., 2, 293-300.
281. Knekt, P., Steineck, G., Järvinen, R., Hakulinen, T. and Aromaa, A. (1994) Intake of fried meat and risk of cancer: a follow-up study in Finland. Int. J. Cancer, 59, 756-760.
282. Probst-Hensch, N.M., Sinha, R., Longnecker, M.P., Witte, J.S., Ingles, S.A., Frankl, H.D., Lee, E.R. and Haile, R.W. (1997) Meat preparation and colorectal adenomas in a large signoidoscopy-based case-control study in California (United States). Cancer Causes Control, 8, 175-183.
283. Lang, N.P., Butler, MA., Massengill, J., Lawson, M., Stotts, R.C., Hauer-Jensen, M. and Kadlubar, F.F. (1994) Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food borne heterocyclic amines increase the risk for colorectal cancer or polyps. Cancer Epidemiol. Biomarkers Prev., 3, 675-682.
284. Sinha, R., Chow, W.H., Kulldorff, M., Denobile, J., Lang, N.P., Kadlubar, F.F., Hoover, R.N. and Rothman, N. (1998) Well done, grilled red meat, 2-amino-3,8-dimethylimidazo[4,5-F]quinoxaline (MeIQx), metabolizing enzymes and risk of colorectal adenomas. Proc. Am. Assoc. Cancer Res., 39, 365.
285. Augustsson, K., Skog, K., Jägerstad, M. and Steineck, G. (1997) Assessment of the human exposure to heterocyclic amines. Carcinogenesis, 18, 1931-1935.
286. Lynch, A.M., Murray, S., Gooderham, N.J. and Boobis, A.R. (1995) Exposure to and activation of dietary heterocyclic amines in humans. Crit. Rev. Oncol J Hematol., 21, 19-31.
287. Yanagisawa, H., Manabe, S., Kitagawa, Y., Ishikawa, S., Nakajima, K. and Wada, O. (1986) Presence of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in dialysate from patients with uremia. Biochem. Biophys. Res. Commun., 138, 1084-1089.
288. Murray, S. Gooderham, N.J., Boobis, A.R. and Davies, D.S. (1989) Detection and measurement of MeIQx in human urine after ingestion of a cooked meat meal. Carcinogenesis, 10, 763-765.
289. Ushiyama, H., Wakabayashi, K., Hirose, M., Itoh, H., Sugimura, T. and Nagao, M. (1991) Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not in patients receiving parenteral alimentation. Carcinogenesis, 12, 1417-1422.
290. Ji, H., Yu, M.C., Stillwell, W.G., Skipper, P.L., Ross, R.K., Henderson, B.E. and Tannenbaum, S.R. (1994) Urinary excretion of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in white, black and Asian men in Los Angeles county. Cancer Epidemiol. Biomarkers Prev., 3, 407-411.
291. Lynch, A.M., Knize, M.G., Boobis, A.R., Gooderham, N.J., Davies, D.S. and Murray, S. (1992) Intra-and interindividual variability in systemic exposure in humans to 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline and 2-amino-1-methyl-6-phenylimidazo[4,5-b)pyridine, carcinogens present in cooked beef. Cancer Res., 52, 6216-6223.
292. x). Cancer Epidemiol. Biomarkers Prev., 3, 399-405.
293. Boobis, A.R., Gooderham, N.J., Edwards, R.J., Murray, S., Lynch, A.M., Yadollahi-Farsani, M. and Davis, D.S. (1996) Enzymic and interindividual differences in the human metabolism of heterocyclic amines. Arch. Toxicol., 18 (suppl.), 286-302.
294. Davies, D.S., Gooderham, N.J., Murray, S., Lynch, A., de la Torre, R., Segura, J. and Boobis, A.R. (1996) Chemical methods for assessing systemic exposure to dietary heterocyclic amines in man. Arch. Toxicol., 18 (suppl.), 251-258.
295. Stillwell, W.G., Kidd, L.C.R., Wishnok, J.S., Tannenbaum, S.R. and Sinha, R. (1997) Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline in humans: relationship to cytochrome P4501A2 and N-acetyltransferase activity. Cancer Res., 57, 3457-3464.
296. Sinha, R., Rothman, N., Mark, S.D. et al. (1995) Lower levels of urinary 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in humans with higher CYP1A2 activity. Carcinogenesis, 16, 2859-2861.
297. Gold, L.S., Slone, T.H., Manley, N.B. and Ames, B.N. (1994) Heterocyclic amines formed by cooking food: comparison of bioassay results with other chemicals in the Carcinogenic Potency Base. Cancer Lett., 83, 21-29.
298. Stavric, B. (1994) Biological significance of trace levels of mutagenic heterocyclic aromatic amines in human diet: a critical review. Food Chem. Toxicol., 32, 977-994.
299. Ward, M.H., Sinha, R., Heineman, E.F., Rothman, N., Markin, R., Weisenburger, D.D., Correa, P. and Zahm, S.H. (1997) Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference. Int. J. Cancer, 28, 14-19.
300. Turesky, R.J., Constable, A., Richoz, J., Varga, N., Markovic, J., Martin, M.V. and Guengerich, F.P. (1998) Activation of heterocyclic aromatic amines by rat and human liver microsomes and by purified rat and human cytochrome P450 1A2. Chem. Res. Toxicol., 11, 925-936.